| Abaxis is engaged in developing, manufacturing and marketing portable blood analysis systems for use in the human or veterinary patient-care to provide clinicians with blood constituent measurements. Co. has two business segments: medical market, with products manufactured and sold in this segment primarily consist of Piccolo chemistry analyzers and medical reagent discs; and veterinary market, with product offerings that include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests. We show 36 historical shares outstanding datapoints in our ABAX shares outstanding history coverage, used to compute ABAX market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABAX market cap history over the course of time is important for investors
interested in comparing ABAX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABAX versus a peer is one thing; comparing
ABAX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABAX can fluctuate over the course of history.
With this page we aim to empower investors researching ABAX by allowing them to research the ABAX market cap history.